Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris W J M van Goor

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of Surgery|July 22, 2022
Alternative Randomized Trial Designs in Surgery: A Systematic ReviewSimone Augustinus, Iris W J M van Goor, Johannes Berkhof, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2023
Predicting post-recurrence survival for patients with pancreatic cancer recurrence after primary resection: A Bi-institutional validated risk classificationA Floortje van Oosten, Lois A Daamen, Vincent P Groot, et al.
Acta Oncologica (Stockholm, Sweden)|December 9, 2021
Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linacLois A Daamen, Sophie R de Mol van Otterloo, Iris W J M van Goor, et al.
Clinical and Translational Radiation Oncology|August 28, 2024
Radiation response assessment of organoids derived from patients with pancreatic cancerIris W J M van Goor, Leon Raymakers, Daan S H Andel, et al.
Annals of Surgery|February 10, 2025
Implications of Neoadjuvant Therapy on Prognostic Factors in Pancreatic Ductal Adenocarcinoma: A Path Towards Personalized PrognosticationAmmar A Javed, Joseph R Habib, Paul C M Andel, et al.
BJS Open|March 23, 2023
Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, observational cohort studyAnne Claire Henry, Jelle C van Dongen, Iris W J M van Goor, et al.
Annals of Surgery|June 3, 2025
Routine Imaging After Resection of Pancreatic Ductal Adenocarcinoma: Nationwide Utilization and Survival AnalysisIris W J M van Goor, Paul C M Andel, Simone Augustinus, et al.
Annals of Surgical Oncology|November 7, 2025
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal AdenocarcinomaPaul C M Andel, Iris W J M van Goor, Thijs J Schouten, et al.
Annals of Surgery|July 14, 2023
Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort StudyIris W J M van Goor, Thijs J Schouten, Daphne N Verburg, et al.
Annals of Surgical Oncology|February 22, 2024
The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide AnalysisThijs J Schouten, Iris W J M van Goor, Galina A Dorland, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of Surgery|July 22, 2022
Alternative Randomized Trial Designs in Surgery: A Systematic ReviewSimone Augustinus, Iris W J M van Goor, Johannes Berkhof, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2023
Predicting post-recurrence survival for patients with pancreatic cancer recurrence after primary resection: A Bi-institutional validated risk classificationA Floortje van Oosten, Lois A Daamen, Vincent P Groot, et al.
Acta Oncologica (Stockholm, Sweden)|December 9, 2021
Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linacLois A Daamen, Sophie R de Mol van Otterloo, Iris W J M van Goor, et al.
Clinical and Translational Radiation Oncology|August 28, 2024
Radiation response assessment of organoids derived from patients with pancreatic cancerIris W J M van Goor, Leon Raymakers, Daan S H Andel, et al.
Annals of Surgery|February 10, 2025
Implications of Neoadjuvant Therapy on Prognostic Factors in Pancreatic Ductal Adenocarcinoma: A Path Towards Personalized PrognosticationAmmar A Javed, Joseph R Habib, Paul C M Andel, et al.
BJS Open|March 23, 2023
Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, observational cohort studyAnne Claire Henry, Jelle C van Dongen, Iris W J M van Goor, et al.
Annals of Surgery|June 3, 2025
Routine Imaging After Resection of Pancreatic Ductal Adenocarcinoma: Nationwide Utilization and Survival AnalysisIris W J M van Goor, Paul C M Andel, Simone Augustinus, et al.
Annals of Surgical Oncology|November 7, 2025
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal AdenocarcinomaPaul C M Andel, Iris W J M van Goor, Thijs J Schouten, et al.
Annals of Surgery|July 14, 2023
Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort StudyIris W J M van Goor, Thijs J Schouten, Daphne N Verburg, et al.
Annals of Surgical Oncology|February 22, 2024
The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide AnalysisThijs J Schouten, Iris W J M van Goor, Galina A Dorland, et al.
Pageof 2